PRAX (STOCKS)
Praxis Precision Medicines, Inc. Common Stock
$317.000000
+0.860000 (+0.27%)
Prev close: $316.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marcio Souza
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,827.04M
- Employees
- 82
- P/E (TTM)
- -23.54
- P/B (TTM)
- 9.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $22.93M |
| Operating Expenses | $326.20M |
| Research and Development | $267.12M |
| Other Operating Expenses | $59.08M |
| Operating Income/Loss | -$326.20M |
| Income/Loss From Continuing Operations After Tax | -$303.27M |
| Income/Loss From Continuing Operations Before Tax | -$302.80M |
| Income Tax Expense/Benefit | $471.00K |
| Income Tax Expense/Benefit, Current | $471.00K |
| Net Income/Loss | -$303.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$303.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$303.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$13.48 |
| Diluted Earnings Per Share | -$13.48 |
| Basic Average Shares | 22,504,676 |
| Diluted Average Shares | 22,504,676 |
| Assets | $937.91M |
| Current Assets | $610.91M |
| Cash | $926.10M |
| Noncurrent Assets | $327.00M |
| Fixed Assets | $147.00K |
| Other Non-current Assets | $326.85M |
| Liabilities | $59.77M |
| Current Liabilities | $59.77M |
| Accounts Payable | $24.63M |
| Other Current Liabilities | $35.14M |
| Noncurrent Liabilities | $0.00 |
| Equity | $878.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $878.14M |
| Liabilities And Equity | $937.91M |
| Net Cash Flow From Operating Activities | -$249.07M |
| Net Cash Flow From Operating Activities, Continuing | -$249.07M |
| Net Cash Flow From Investing Activities | -$311.15M |
| Net Cash Flow From Investing Activities, Continuing | -$311.15M |
| Net Cash Flow From Financing Activities | $702.17M |
| Net Cash Flow From Financing Activities, Continuing | $702.17M |
| Net Cash Flow | $141.96M |
| Net Cash Flow, Continuing | $141.96M |
| Comprehensive Income/Loss | -$303.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$303.36M |
| Other Comprehensive Income/Loss | -$303.36M |